Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …

OBJECTIVES The purpose of the study was to investigate the effects of beta 1 -blockade on
left ventricular (LV) size and function for patients with chronic heart failure. BACKGROUND …

Background : Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …

Despite continuing efforts during the last decades, there is no ‘ideal prosthetic valve substitute’.
Every valve prosthesis invokes new pathophysiological processes, including the risks of …

Background— Phase 1 clinical trials of granulocyte-colony stimulating factor (G-CSF) treatment
after myocardial infarction have indicated that G-CSF treatment is safe and may improve …

Background : Transcatheter aortic valve replacement (TAVR) is an alternative to surgical
aortic valve replacement (SAVR) in patients with severe aortic stenosis and intermediate or …

Background: Percutaneous closure of the left atrial appendage (LAA) is an alternative to
chronic oral anticoagulation to reduce stroke risk in patients with nonvalvular atrial fibrillation. …

Aims The aims of the study were to compare clinical outcomes and valve durability after 8
years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk …

Despite major improvements in transcatheter aortic valve replacement (TAVR) periprocedural
complications in recent years, the occurrence of conduction disturbances has not …